AGYTF
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
512.61M
APNHF
Price
$7.25
Change
-$4.99 (-40.77%)
Updated
Jun 6 closing price
Capitalization
2.6B
Interact to see
Advertisement

AGYTF vs APNHF

Header iconAGYTF vs APNHF Comparison
Open Charts AGYTF vs APNHFBanner chart's image
Allergy Therapeutics
Price$0.09
Change-$0.00 (-0.00%)
Volume$300
Capitalization512.61M
Aspen Pharmacare Holdings
Price$7.25
Change-$4.99 (-40.77%)
Volume$407
Capitalization2.6B
AGYTF vs APNHF Comparison Chart in %
Loading...
APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGYTF vs. APNHF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGYTF is a Hold and APNHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AGYTF: $0.09 vs. APNHF: $7.25)
Brand notoriety: AGYTF and APNHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AGYTF: 66% vs. APNHF: 100%
Market capitalization -- AGYTF: $512.61M vs. APNHF: $2.6B
AGYTF [@Pharmaceuticals: Generic] is valued at $512.61M. APNHF’s [@Pharmaceuticals: Generic] market capitalization is $2.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGYTF’s FA Score shows that 1 FA rating(s) are green whileAPNHF’s FA Score has 1 green FA rating(s).

  • AGYTF’s FA Score: 1 green, 4 red.
  • APNHF’s FA Score: 1 green, 4 red.
According to our system of comparison, AGYTF is a better buy in the long-term than APNHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHF’s TA Score shows that 1 TA indicator(s) are bullish.

  • APNHF’s TA Score: 1 bullish, 0 bearish.

Price Growth

AGYTF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while APNHF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHF($2.6B) has a higher market cap than AGYTF($513M). AGYTF YTD gains are higher at: 63.462 vs. APNHF (-40.792).
AGYTFAPNHFAGYTF / APNHF
Capitalization513M2.6B20%
EBITDAN/A8.02B-
Gain YTD63.462-40.792-156%
P/E RatioN/A12.68-
RevenueN/A45.5B-
Total CashN/A6.8B-
Total DebtN/A35.5B-
FUNDAMENTALS RATINGS
AGYTF vs APNHF: Fundamental Ratings
AGYTF
APNHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
4482
P/E GROWTH RATING
1..100
689
SEASONALITY SCORE
1..100
5015

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHF's Valuation (13) in the null industry is significantly better than the same rating for AGYTF (89). This means that APNHF’s stock grew significantly faster than AGYTF’s over the last 12 months.

APNHF's Profit vs Risk Rating (100) in the null industry is in the same range as AGYTF (100). This means that APNHF’s stock grew similarly to AGYTF’s over the last 12 months.

AGYTF's SMR Rating (95) in the null industry is in the same range as APNHF (99). This means that AGYTF’s stock grew similarly to APNHF’s over the last 12 months.

AGYTF's Price Growth Rating (44) in the null industry is somewhat better than the same rating for APNHF (82). This means that AGYTF’s stock grew somewhat faster than APNHF’s over the last 12 months.

AGYTF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for APNHF (89). This means that AGYTF’s stock grew significantly faster than APNHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGYTFAPNHF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
25%
Bullish Trend 4 days ago
20%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
25%
Bullish Trend 4 days ago
21%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LISGX74.190.27
+0.37%
ClearBridge Small Cap IS
HWGAX16.380.02
+0.12%
Hotchkis & Wiley Global Value A
TEDIX32.480.03
+0.09%
Franklin Mutual Global Discovery A
IJPMX13.51-0.01
-0.07%
VY® JPMorgan Mid Cap Value S2
EIVFX14.66-0.02
-0.14%
Allspring Special Large Cap Value R6

AGYTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGYTF has been loosely correlated with YCBD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AGYTF jumps, then YCBD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGYTF
1D Price
Change %
AGYTF100%
N/A
YCBD - AGYTF
39%
Loosely correlated
+1.44%
SDZXF - AGYTF
20%
Poorly correlated
N/A
PRFX - AGYTF
0%
Poorly correlated
-12.62%
APNHF - AGYTF
0%
Poorly correlated
N/A
ARSUF - AGYTF
0%
Poorly correlated
N/A
More

APNHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, APNHF has been closely correlated with BGM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if APNHF jumps, then BGM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHF
1D Price
Change %
APNHF100%
N/A
BGM - APNHF
73%
Closely correlated
-2.16%
MSTH - APNHF
34%
Loosely correlated
N/A
PBH - APNHF
26%
Poorly correlated
-2.55%
YCBD - APNHF
1%
Poorly correlated
+1.44%
ABSCF - APNHF
1%
Poorly correlated
N/A
More